Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version
For acute lymphoblastic leukemia (ALL), the 5-year survival rate has improved significantly since 1975. Get information about risk factors, signs, diagnosis, molecular features, survival, risk-based treatment assignment, and induction and postinduction therapy for children and adolescents with newly diagnosed and recurrent ALL.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/3705/syndication
- Syndication ID: 1492
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Saturday, September 14, 2013 at 09:01 AM
- Date Syndication Updated: Monday, August 05, 2019 at 07:42 PM
childhood acute lymphoblastic leukemia
T-cell childhood acute lymphoblastic leukemia
Philadelphia chromosome-positive childhood acute lymphoblastic leukemia
Embed Code Snippet
To get the embed code snippet please Login.